16 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
determines that an event, incident or circumstance has occurred that may result in the need for a recall or market withdrawal in the Territory … similar action in connection with the Licensed Compound or Licensed Product or in the event Licensor determines that an event, incident
F-3
EX-1.2
CNTB
Connect Biopharma Holdings Ltd
15 Apr 22
Shelf registration (foreign)
5:27pm
with the provisions of Section 11 hereunder, will pay all expenses incident to the performance of its obligations hereunder, including expenses
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
revenues, and other obligations incident to doing business in another country;
foreign reimbursement, pricing and insurance regimes;
difficulty … of potential loss, if any, that could result therefrom. If we cannot successfully resolve a security incident or contain any potential loss, it could
6-K
EX-99.1
l65b970e5mw8bdfn
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
77godr77s4w
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
0onukg4moro2tslehv
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
tt9wtf8 7p0pn
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
u97nn149
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
y9985si g5mg0n
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.1
d2p6t
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
vjbbfxybpce
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
r2hmx5
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
EX-10.1
8kydso26vatwz1r
17 Dec 20
Draft registration statement
12:00am
DRS
1wk3bc 8het2t
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next